Only forward issues concerning Immunovative will be discussed at the June 2 meeting. The relationship with Tauriga won't be discussed, and no questions on this issue will be answered.
All Tauriga shareholders are, however, welcome to attend.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.